175871-45-1

Basic information

• Product Name: 1,2,3,4-TETRAHYDRO-ISOQUINOLIN-7-YLAMINE HCL
• Synonyms: 7-AMINO-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE;1,2,3,4-TETRAHYDRO-ISOQUINOLIN-7-YLAMINE HCL;1,2,3,4-tetrahydro-7-Isoquinolinamine hydrochloride;7-AMINO-1,2,3,4-TETRAHYDRO-ISOQUINOLINE HCL
• CAS NO: 175871-45-1
• Molecular Formula: C9H13ClN2
• Molecular Weight: 184.67
• EINECS: -0
• Mol File: 175871-45-1.mol

Chemical Properties

• Boiling Point: 344.7°C at 760 mmHg
• Flash Point: 162.3°C
• Appearance: /
• Vapor Pressure: 4.59E-05mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 1,2,3,4-TETRAHYDRO-ISOQUINOLIN-7-YLAMINE HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-TETRAHYDRO-ISOQUINOLIN-7-YLAMINE HCL(175871-45-1)
• EPA Substance Registry System: 1,2,3,4-TETRAHYDRO-ISOQUINOLIN-7-YLAMINE HCL(175871-45-1)

Safety Data

• Hazardous Substances Data: 175871-45-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydro-isoquinolin-7-ylamine HCl is used as a CNS depressant for its potential role in treating neurological disorders and psychiatric conditions due to its calming effects on the central nervous system.
Used in Neurological Disorder Treatment:
In the field of neurology, 1,2,3,4-Tetrahydro-isoquinolin-7-ylamine HCl is used as a potential therapeutic agent for managing neurological disorders, leveraging its CNS depressant properties to alleviate symptoms.
Used in Psychiatric Condition Management:
1,2,3,4-Tetrahydro-isoquinolin-7-ylamine HCl is utilized as a component in psychiatric treatments, where its depressive effects on the CNS can be beneficial in managing the symptoms of certain psychiatric conditions.
Used in Movement Disorder Treatment:
Specifically within the treatment of movement disorders, 1,2,3,4-Tetrahydro-isoquinolin-7-ylamine HCl is used as a dopamine receptor agonist, making it a candidate for the treatment of Parkinson's disease and other related conditions, due to its potential to influence dopaminergic pathways.
Used in Pharmaceutical Formulations:
Owing to its HCl salt form, 1,2,3,4-Tetrahydro-isoquinolin-7-ylamine HCl is used in the development of stable pharmaceutical formulations, ensuring the compound's effectiveness and safety in medical applications.

InChI:InChI=1/C9H12N2.ClH/c10-9-2-1-7-3-4-11-6-8(7)5-9;/h1-2,5,11H,3-4,6,10H2;1H

Upstream product

• 99365-69-2 7-nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride 

Relevant articles and documents

COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

The present invention relates to a class of small molecule hydroxamic acid compounds capable of inhibiting histone deacetylases (HDACs). The present invention also relates to methods of preparation of hydroxamic acid HDAC inhibitor compounds of the invent